PolyPid
PYPD
27 hedge funds and large institutions have $4.91M invested in PolyPid in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 4 closing their positions.
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
61% more call options, than puts
Call options by funds: $462K | Put options by funds: $287K
0% more funds holding
Funds holding: 27 → 27 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
0.07% less ownership
Funds ownership: 0.27% → 0.2% (-0.07%)
44% less capital invested
Capital invested by funds: $8.71M → $4.91M (-$3.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$395K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$332K |
| 3 |
JWM
JFG Wealth Management
Denver,
Colorado
|
+$197K |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$120K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$111K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$2.05M |
| 2 |
MCM
Moore Capital Management
New York
|
-$719K |
| 3 |
Barclays
London,
United Kingdom
|
-$408K |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$115K |
| 5 |
VF
Virtu Financial
New York
|
-$78K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$1.82K | +12 | New |
|
|
SCM
27
Silverarc Capital Management
Boston,
Massachusetts
| $1.19K | +$13K | +86 | +1% |
|
|
MCM
28
Moore Capital Management
New York
| – | -$719K | -4,173 | Closed |
|
|
29
Barclays
London,
United Kingdom
| – | -$408K | -2,367 | Closed |
|
|
30
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$115K | -667 | Closed |
|
|
VF
31
Virtu Financial
New York
| – | -$78K | -454 | Closed |
|
PYPD Hedge Fund Activity: Q1 2022 in Review
27 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in PolyPid (PYPD) for Q1 2022, worth a combined $4.91M — down 44% from $8.71M a quarter earlier.
Fund positioning in PYPD was balanced in Q1 2022: 4 funds opened new positions, 4 closed out, 9 added to existing stakes and 5 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $395K. The largest seller was ARK Investment Management, cutting an estimated $2.05M.
- 27 institutional investors held PolyPid (PYPD) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $4.91M of PolyPid stock for Q1 2022, down 44% quarter-over-quarter.
- 4 funds opened new PolyPid positions in Q1 2022 and 4 closed out, a net change of 0 holders.
- The largest PolyPid buyer in Q1 2022 was Morgan Stanley, an estimated $395K added.
- The largest PolyPid seller in Q1 2022 was ARK Investment Management, an estimated $2.05M sold.
Based on aggregated 13F filings for Q1 2022.